Table 4 |
||||
|
Baseline characteristics of the 60 included patients compared to the 70 patients who had to be excluded due to non-study related reasons. |
||||
|
Parameter |
Patients in INSECT trial (n = 60) |
Patients not consenting (n = 44) |
Patients in POVATI trial (n = 26) |
p-value |
|
|
||||
|
Age |
||||
|
|
||||
|
Mean (SD) |
57.70 (17.08) |
55.93 (17.54) |
56.69 (12.27) |
0.6088* |
|
|
||||
|
Gender |
||||
|
|
||||
|
female |
21 (35.00%) |
17 (38.64%) |
9 (34.62%) |
|
|
|
||||
|
male |
39 (65.00%) |
27 (61.36%) |
17 (65.38%) |
|
|
|
||||
|
0.9158# |
||||
|
|
||||
|
Body Mass Index |
||||
|
|
||||
|
Mean (SD) |
25.62 (3.41) |
24.61 (3.60) |
23.77 (2.51) |
0.0786* |
|
|
||||
|
ASA score |
||||
|
|
||||
|
I |
4 (6.67%) |
2 (4.55%) |
2 (7.69%) |
|
|
|
||||
|
II |
34 (56.67%) |
27 (61.36%) |
15 (57.69%) |
|
|
|
||||
|
III |
21 (35.00%) |
15 (34.09%) |
9 (34.62%) |
|
|
|
||||
|
IV |
1 (1.67%) |
0 (0.00%) |
0 (0.00%) |
|
|
|
||||
|
0.9931# |
||||
|
|
||||
|
Duration of hospitalization |
||||
|
|
||||
|
Mean (SD) |
14.61 (11.76) |
14.34 (11.64) |
13.00(6.90) |
0.9570* |
|
|
||||
|
Malignant disease |
||||
|
|
||||
|
none |
35 (58.33%) |
19 (43.18%) |
10 (38.46%) |
|
|
|
||||
|
solid tumors |
24 (40.00%) |
25 (56.82%) |
16 (61.54%) |
|
|
|
||||
|
missing/n.a. |
1 (1.67%) |
0 (0.00%) |
0 (0.00%) |
|
|
|
||||
|
0.1634# |
||||
|
|
||||
|
Incision technique |
||||
|
|
||||
|
midline |
60 (100.00%) |
40 (90.91%) |
18 (69.23%) |
|
|
|
||||
|
transverse |
0 (0.00%) |
3 (6.82%) |
8 (30.77%) |
|
|
|
||||
|
laparoscopic |
0 (0.00%) |
1 (2.27%) |
0 (0.00%) |
|
|
|
||||
|
0.0001# |
||||
|
|
||||
|
Closure technique |
||||
|
|
||||
|
continuous suture |
40 (66.67%) |
39 (88.64%) |
26 (100.00%) |
|
|
|
||||
|
interrupted suture |
20 (33.33%) |
4 (9.09%) |
0 (0.00%) |
|
|
|
||||
|
missing/n.a. |
0 (0.00%) |
1 (2.27%) |
0 (0.00%) |
|
|
|
||||
|
0.0006# |
||||
|
|
||||
|
* Kruskal-Wallis test, # Fisher's exact test |
||||
|
Fischer et al. BMC Surgery 2012 12:2 doi:10.1186/1471-2482-12-2 |
||||
